CapsoVision CV
NASDAQ CV
$5.91 -0.21 (-3.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

CapsoVision (CV) Return on Assets (2025 - 2026)

CapsoVision (CV) posted Return on Assets of 0.01% for Q4 2025, up 14.07% sequentially from 0.01% in Q3 2025.

CapsoVision (CV) Return on Assets (2025 - 2026) Analysis & Trends

CapsoVision has reported Return on Assets for 1 years, with the latest figure at 0.01% in Q4 2025.

  • Quarterly Return on Assets changed N/A year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY) and the FY2025 annual result came in at 0.01%, changed N/A from the prior year.
  • Return on Assets improved to 0.01% in Q4 2025 per CV's latest filing, from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.01% in Q4 2025 and troughed at 0.02% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.00%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.00%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.00%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.00%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.00%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 0.00%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.00%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.00%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.00%
10 CapsoVision 295.13 Mn 286.05 Mn 1.87 Mn -0.01%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.02%